# Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

> **NCT04746638** · PHASE1 · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer
- Breast Cancer Female

## Interventions

- **DIAGNOSTIC_TEST:** whole body study and SPECT with 99mTc-RM26

## Key facts

- **NCT ID:** NCT04746638
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-05-19
- **Final completion:** 2023-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746638, "Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04746638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*